GEODE CAPITAL MANAGEMENT, LLC

Position in ALLR — Allarity Therapeutics, Inc.

CIK 1214717 BOSTON, MA

Position in ALLR

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$199,777

-$7,751 QoQ

Shares Held

154,867

-18.7% QoQ

Ownership

0.973%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 20 holders

Holding Since

Mar 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. ALLR ranks #401 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,017,848	$2,989,245,636
2	REGN	Regeneron Pharmaceuticals, Inc.	2,625,810	$1,637,297,566
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,635,840	$793,466,914
4	RVMD	Revolution Medicines, Inc.	3,942,676	$738,384,360
5	MRNA	Moderna, Inc.	9,710,335	$680,014,759
6	INCY	Incyte Corp	4,750,735	$538,543,319
7	RPRX	Royalty Pharma plc	8,058,048	$451,814,751
8	INSM	INSMED Inc	4,220,155	$449,952,925

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$199,777	154,867	-18.7%	Shares	Defined	2026-08-12
2026-03-31	$207,528	190,393	+21.5%	Shares	Defined	2026-05-15
2025-12-31	$169,170	156,640	+3.1%	Shares	Defined	2026-02-09
2025-09-30	$240,044	151,927	+200.0%	Shares	Defined	2025-11-12
2025-06-30	$51,155	50,650	+49.3%	Shares	Defined	2025-08-08
2025-03-31	$31,783	33,921	-66.9%	Shares	Defined	2025-05-13
2024-06-30	$21,795	102,328	+247.7%	Shares	Defined	2024-08-09
2022-12-31	$8,653	29,433	0.0%	Shares	Defined	2023-02-13
2022-09-30	—	29,433	0.0%	Shares	Defined	2022-11-14
2022-06-30	—	29,433	+139.0%	Shares	Defined	2022-08-12
2022-03-31	—	12,315	—	Shares	Defined	2022-05-13
No filing history on record for this holder in this stock.